Skip to main content
Benjamin Suratt, MD, Pulmonology, Essex Junction, VT

BenjaminTateSurattMD

Pulmonology Essex Junction, VT

Critical Care Medicine

Director, Early Development, Immunity & Inflammation, Sanofi

Dr. Suratt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Suratt's full profile

Already have an account?

  • Office

    6 Deer Crossing Ln
    Essex Junction, VT 05452

Summary

  • Dr. Benjamin Suratt is a pulmonologist in Essex Junction, VT. He received his medical degree from Columbia University Vagelos College of Physicians and Surgeons and has been in practice 26 years. He specializes in critical care medicine and is experienced in critical care medicine, acute lung injury, and cancer survivorship.

Education & Training

  • University of Colorado
    University of ColoradoFellowship, Pulmonary Disease and Critical Care Medicine, 1997 - 2000
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 1993 - 1996
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 1993, MD, AOA
  • Amherst College
    Amherst CollegeBA, Interdisciplinary , summa cum laude, 1984 - 1988

Certifications & Licensure

  • VT State Medical License
    VT State Medical License 2002 - 2024
  • CO State Medical License
    CO State Medical License 1998 - 2003
  • MA State Medical License
    MA State Medical License 1995 - 1998
  • American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Publications & Presentations

PubMed

Press Mentions

  • In ARDS, Heterogeneity = Opportunity
    In ARDS, Heterogeneity = OpportunityApril 4th, 2017

Grant Support

  • Klebsiella Pneumoniae Pathogenesis in the Obese LungNational Institute of Allergy and Infectious Diseases2020–2022
  • Ketone Body Supplementation in Obese AsthmaNational Heart, Lung, And Blood Institute2018–2022
  • Unfolded protein response in influenza virus infection and inflammationNational Heart, Lung, And Blood Institute2018–2022
  • Effects of Exercise on Inflammation-Induced Lung and Muscle Injury in Critical Illness (NEXIS-FLAME)National Heart, Lung, And Blood Institute2018–2022
  • Developing obese mouse models of Pseudomonas aeruginosa pneumoniaNational Institute of Allergy and Infectious Diseases2015–2017
  • Serum Amyloid A3 in Allergic Asthma: An Endogenous Mediator of Disease SeverityNational Heart, Lung, And Blood Institute2012–2017
  • Nitrogen Dioxide in the Sensitization to Allergic Airway DiseaseNational Heart, Lung, And Blood Institute2007–2012
  • Reciprocal Regulation Of SDF-1 Between Marrow And Lung During Acute Lung InjuryNational Heart, Lung, And Blood Institute2006–2010
  • Reciprocal Regulation Of SDF-1 Between Marrow And Lung During Acute Lung InjuryNational Center For Research Resources2006–2007
  • Neutrophil Homeostasis In Lung InflammationNational Heart, Lung, And Blood Institute2002–2005
  • Neutrophil Homeostasis In Lung InflammationNational Heart, Lung, And Blood Institute2001–2002